.jpg "Tao Zhang, Ph.D. photo")
Assistant Professor
Binghamton University
Tao Zhang received his bachelor's degree in biotechnology from Zhejiang University, PR China, in 2003; his master's degree in environmental science from Hong Kong University of Science and Technology, Hong Kong, PR China, in 2005; and his PhD in pharmaceutical sciences from the University of Michigan in 2010. He then worked in the Drug Metabolism and Pharmacokinetics (DMPK) Department at Novartis Pharmaceuticals Corporation in New Jersey from 2010 to 2014, before joining Husson University School of Pharmacy as an assistant professor. He was promoted to associate professor at Husson in 2020. Zhang joined the School of Pharmacy and Pharmaceutical Sciences at Binghamton University as an assistant professor in 2022.
Zhang’s primary research focuses on translational research by utilizing in vitro, in vivo and in silico approaches to evaluate drug safety and efficacy and support drug development in humans. His laboratory conducts preclinical drug absorption, distribution, metabolism and excretion (ADME) studies and utilizes pharmacokinetic (PK) modeling tools to build PK, pharmacokinetic/pharmacodynamic (PK/PD) and physiologically based pharmacokinetic (PBPK) models to optimize drug dosage regimens and assess drug safety. He also studies molecular mechanisms and therapeutic uses of naturally derived bioactive compounds and their interaction with gut microbiomes for cancer/inflammation drug discovery.
His research has been supported by the FDA, USDA and other foundations. He has published over 40 research articles in peer-reviewed journals with more than 3,000 citations. He has years of experience in teaching courses covering topics of basic and clinical pharmacokinetics, pharmaceutics, pharmacogenomics and clinical research design.